# Metagenomi Therapeutics, Inc.: Form 8-K, filed May 13, 2025

- Company: [Metagenomi Therapeutics, Inc.](/companies/mgx.md) (CIK 1785279)
- Form: 8-K
- Filed: 2025-05-13
- Accepted by EDGAR: May 13, 2025, 16:35 ET
- Period: 2025-05-13
- Accession: 0000950170-25-070448
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1785279/000095017025070448/mgx-20250513.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785279/000095017025070448/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785279/000095017025070448/mgx-20250513.htm

Filed May 13, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-070448. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.